End-expiratory Occlusion Test and Prediction of Preload Dependence
NCT ID: NCT05874531
Last Updated: 2023-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2023-05-15
2023-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound and Clinical Approach for the Dynamic Assessment of Fluid Tolerance in the Intensive Care Unit
NCT06415916
Evaluation of the Variation of the Sub-pulmonary Velocity-time Integral to Predict Fluid Responsiveness
NCT07202637
Study of End Tidal Carbon Dioxide (EtCO2) Variation After an End- Expiratory Occlusion Test as a Predictive Criteria of Fluid Responsiveness in Mechanically Ventilated Patients
NCT04889807
Fluid Responsiveness Prediction During Prone Position
NCT05898269
Fluid Responsiveness Prediction at the Bedside
NCT00721604
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A venous access to the superior vena cava territory (central venous catheter) was set up.
The patients were sedated with a Ramsay score \> 4 and ventilated in controlled assisted mode.
The sub-aortic TVI (in cm) was measured in an apical 5-chamber section by pulsed Doppler using a 1-5 MHz ultrasound probe (M-Turbo sonosite). Three sets of measurements of hemodynamic parameters and sub-aortic VTI were performed: before and at the end of 15 seconds end-expiratory occlusion and after 250 mL saline administration over 10 minutes. At each point, the investigators noted the hemodynamic, ultrasound and biological parameters.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Responders to fluid challenge
Responders to fluid loading after an increase in sub-aortic VTI of more than 10% following a volume expansion.
End-expiratory occlusion test
15 seconds end-expiratory occlusion
Non responders to fluid challenge
Non responders to fluid loading after an increase in sub-aortic VTI of more than 10% following a volume expansion.
End-expiratory occlusion test
15 seconds end-expiratory occlusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
End-expiratory occlusion test
15 seconds end-expiratory occlusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients for whom the decision of 250 mL saline administration was taken for : hypotension (systolic pression under 90 mmHg or diatolic pression under 40 mmHg or tachycardia more than 90 pulse per minute or oliguria or the increase in cathecholamin needs.
Exclusion Criteria
* arrythmia
* dialysis
* Prone position
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mongi Slim Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mhamed Sami Mebazaa
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mhamed Sami MS Mebazaa, Pr
Role: PRINCIPAL_INVESTIGATOR
Mongi Slim Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mongi Slim hospital
Tunis, , Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TOTE Rea
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.